Company: LHI
Filing Date: 2025-09-29
Form Type: F-1/A
Source: 0001213900-25-092499
Chunk: 10

Company: Living Homeopathy International Ltd.
Filing Date: 2025-09-29
Form: F-1/A
Chunk 10
---
 debts as they fall due in the ordinary course of business.

This prospectus does not constitute, and there will not be, an offering of securities to the public in the Cayman Islands.

Neither the Securities and Exchange Commission nor any state securities commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

|                           |     | Per Share |       |     | Total |           |
|:--------------------------|:----|:----------|------:|:----|:------|----------:|
| Public                    
 offering price(1)         |     | $         |   5.0 |     | $     | 6,250,000 |
| Underwriting              
 discounts(2)              |     | $         | 0.375 |     | $     |   468,750 |
| Proceeds                  
 to us, before expenses(3) |     | $         | 4.625 |     | $     | 5,781,250 |

| (1) | Initial                                                                                                                                  
 public offering price per share is assumed at $5.0 per Class A Ordinary Share, which is the midpoint of the estimated initial public     
 offering price range set forth on the cover page of this prospectus. The table above assumes that the underwriters do not exercise their 
 over-allotment option. For more information, see “Underwriting” beginning on page 123 of this prospectus.                                |

| (2) | An underwriting discount                                                     
 equal to 7.5% of the public offering price will be provided to underwriters. |

| (3) | Living Homeopathy expects                                                                                                          
 its cash expenses for this offering (including cash expenses payable to its underwriter for the underwriter’s out-of-pocket        
 expenses) not to exceed $[●]. For a detailed description of the compensation to be received by the underwriter, see “Underwriting” 
 beginning on page 123 of this prospectus.                                                                                          |

This offering is being
conducted on a firm commitment basis. The underwriters are obligated to take and pay for all of the Class A Ordinary Shares if any such
Class A Ordinary Shares are taken. Assuming an offering price of $5.0 per Ordinary Share, which is the midpoint of the estimated initial
public offering range set forth on the cover page of this prospectus, the total gross proceeds to Living Homeopathy, before underwriting
discount